Policy Reporter’s Multiple Sclerosis (MS) Drugs Market Insights infographic examines a complicated therapeutic space from Aubagio to Zeposia, using data from our formulary database and policy alerts.
Learn key insights such as the impact of newly released brand and generic agents on the landscape. Find out which MS drugs are most often preferred on formularies from top payers, which drugs had the most policy changes based on alerts, and much more.
We use our own and third parties cookies to improve your experience and our services. If you continue browsing, we take that to mean that you accept their uses and information.